Agency for Clinical Innovation
Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise.
最新观测到的下载价格为 免费。请打开 App Store 官方链接确认当前结算价格。
当前在 Apple 公共 App Store 页面可见的项目,可能不等同于 App Store Connect 中的完整目录。
来源:Apple 公共 App Store 页面 · 仅包含公开可见项目
Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise.
Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes.
Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.
根据最新观测到的 App Store 数据快速解答。
最新观测到的下载价格为 免费。请打开 App Store 官方链接确认当前结算价格。
Apple 公开页面目前在该商店显示 0 个购买项目,公开列表可能不完整。